Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Invasive Fungal Infections 1Infections 1Hematologic Neoplasms 1Fusariosis 1Febrile Neutropenia 1

Interventions

Moxifloxacin 2Ciprofloxacin 2telaprevir 1peginterferon alfa-2a 1Voriconazole 1Ribavirin 1Negative-Pressure Wound Therapy 1Immunosuppression Therapy 1Diet 1Cone-Beam Computed Tomography 1Caspofungin 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Infections × Caspofungin × Clear all
NCT00238355 2025-04-27

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

OHSU Knight Cancer Institute

Phase 2 Terminated
13 enrolled 8 charts

Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡